ZA201204018B - Topical foam composition - Google Patents

Topical foam composition

Info

Publication number
ZA201204018B
ZA201204018B ZA2012/04018A ZA201204018A ZA201204018B ZA 201204018 B ZA201204018 B ZA 201204018B ZA 2012/04018 A ZA2012/04018 A ZA 2012/04018A ZA 201204018 A ZA201204018 A ZA 201204018A ZA 201204018 B ZA201204018 B ZA 201204018B
Authority
ZA
South Africa
Prior art keywords
foam composition
topical foam
topical
composition
foam
Prior art date
Application number
ZA2012/04018A
Inventor
Amar Lulla
Geena Malhotra
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of ZA201204018B publication Critical patent/ZA201204018B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/122Foams; Dry foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2012/04018A 2009-11-23 2012-06-01 Topical foam composition ZA201204018B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2703MU2009 2009-11-23

Publications (1)

Publication Number Publication Date
ZA201204018B true ZA201204018B (en) 2012-12-27

Family

ID=43447946

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2012/04018A ZA201204018B (en) 2009-11-23 2012-06-01 Topical foam composition

Country Status (12)

Country Link
EP (1) EP2503989A2 (en)
JP (1) JP2013511570A (en)
KR (1) KR20120117788A (en)
CN (1) CN102724960A (en)
AU (1) AU2010320656B2 (en)
BR (1) BR112012012316A2 (en)
CA (1) CA2781580A1 (en)
MX (1) MX2012005883A (en)
NZ (1) NZ600362A (en)
RU (1) RU2012126084A (en)
WO (1) WO2011061519A2 (en)
ZA (1) ZA201204018B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1698630E (en) 2005-03-03 2014-09-15 Alfa Wassermann Spa New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
ITBO20050123A1 (en) 2005-03-07 2005-06-06 Alfa Wassermann Spa GASTRORESISTIC PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMINA
DE602006006432D1 (en) 2005-03-24 2009-06-04 Nolabs Ab COSMETIC TREATMENT WITH STAIN OXIDE, DEVICE FOR CARRYING OUT THIS TREATMENT, AND METHOD OF MANUFACTURING THEREOF
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
IT1398550B1 (en) 2010-03-05 2013-03-01 Alfa Wassermann Spa RIFAXIMINA COMPREHENSIVE FORMULATIONS USEFUL TO OBTAIN A PROLONGED EFFECT IN TIME
WO2013006608A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Topical compositions
ITBO20110461A1 (en) 2011-07-29 2013-01-30 Alfa Wassermann Spa PHARMACEUTICAL COMPOSITIONS INCLUDING RIFAXIMINA, PROCESSES FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS.
JP6265967B2 (en) * 2012-03-14 2018-01-24 ノヴァン,インコーポレイテッド Pharmaceutical composition
ITBO20120368A1 (en) 2012-07-06 2014-01-07 Alfa Wassermann Spa COMPOSITIONS INCLUDING RIFAXIMINA AND AMINO ACIDS, RIFAXIMINE CRYSTALS DERIVING FROM SUCH COMPOSITIONS AND THEIR USE.
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
CN105979969B (en) 2013-08-08 2020-09-11 诺万公司 Topical compositions and methods of using the same
NZ723571A (en) 2014-05-12 2020-02-28 Alfasigma Spa New solvated crystal form of rifaximin, production, compositions and uses thereof
CA2919733A1 (en) 2014-08-08 2016-02-08 Novan, Inc. Topical compositions and methods of using the same
JP7090549B2 (en) 2016-03-02 2022-06-24 ノヴァン,インコーポレイテッド Therapeutic compositions for inflammation and their treatment methods
CN109310630A (en) 2016-04-13 2019-02-05 诺万公司 For treating composition, system, kit and the method for infection
WO2018109717A1 (en) * 2016-12-16 2018-06-21 Ferring B.V. Rectal foam formulations
US11285171B2 (en) 2018-03-01 2022-03-29 Novan, Inc. Nitric oxide releasing suppositories and methods of use thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2907118A1 (en) 1979-02-20 1980-09-04 Schering Ag NEW PROSTACYCLINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
IT1154655B (en) 1980-05-22 1987-01-21 Alfa Farmaceutici Spa IMIDAZO-RIFAMYCIN DERIVATIVES METHODS FOR THEIR PREPARATION AND USE AS AN ANTIBACTERIAL ACTION SUBSTANCE
IT1199374B (en) 1984-05-15 1988-12-30 Alfa Farmaceutici Spa PROCESS FOR THE PREPARATION OF PIRIDO-IMIDAZO-RIFAMICINE
GB8909559D0 (en) 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
FR2647344B1 (en) 1989-05-25 1995-06-02 Physiopharm Sarl RECTAL USE AEROSOL FOAM
US4946939A (en) 1989-05-30 1990-08-07 The Dow Chemical Company High purity polyether polyols
IT1243379B (en) 1990-07-27 1994-06-10 Giuliani Spa PHARMACEUTICAL COMPOSITION SUITABLE FOR RECTAL ADMINISTRATION OF ACTIVE PRINCIPLES WHICH EXPLICATE A MEDICATION ACTION AT THE LEVEL OF THE COLON, PREVALENTLY TOPICAL
IT1253711B (en) * 1991-12-17 1995-08-23 Alfa Wassermann Spa VAGINAL PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS
IT1264494B1 (en) 1993-03-23 1996-09-24 Alfa Wassermann Spa USE OF RIFAXIMIN AND FORMULATIONS THAT CONTAIN IT IN THE TREATMENT OF GASTRIC DYSPEPSIES ORIGINATED BY HELICOBACTER
IT1290679B1 (en) 1997-02-14 1998-12-10 Alfa Wassermann Spa USE OF RIFAXIMINE AND OF THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT IN THE TREATMENT OF DIARRHEA FROM CRYPTOSPORIDIOSIS.
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
ITMI20032144A1 (en) 2003-11-07 2005-05-08 Alfa Wassermann Spa REFLEXIMINE POLIMORPHIC FORMS, PROCESSES TO OBTAIN THEM AND
PT1698630E (en) 2005-03-03 2014-09-15 Alfa Wassermann Spa New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations
US8987292B2 (en) * 2006-03-09 2015-03-24 Salix Pharmaceuticals, Ltd. Rifaximin anti-rectal dysfunction preparation
SI2294012T1 (en) * 2008-05-07 2014-11-28 Salix Pharmaceuticals, Ltd. Administration of a bowel cleanser and an antibiotic for the treatment of bowel disease
CN101502510B (en) * 2009-03-19 2011-11-09 山东京卫制药有限公司 Medicament composition for treating colpitis symptoms and preparation method thereof

Also Published As

Publication number Publication date
EP2503989A2 (en) 2012-10-03
BR112012012316A2 (en) 2016-04-26
KR20120117788A (en) 2012-10-24
AU2010320656A1 (en) 2012-06-21
CA2781580A1 (en) 2011-05-26
AU2010320656B2 (en) 2015-07-30
JP2013511570A (en) 2013-04-04
NZ600362A (en) 2014-08-29
WO2011061519A3 (en) 2011-10-06
CN102724960A (en) 2012-10-10
WO2011061519A2 (en) 2011-05-26
MX2012005883A (en) 2012-10-09
RU2012126084A (en) 2013-12-27

Similar Documents

Publication Publication Date Title
IL214520A0 (en) Topical foam composition
ZA201204018B (en) Topical foam composition
GB0911562D0 (en) Foam composition
GB0908129D0 (en) Composition
GB0918450D0 (en) Composition
GB0913255D0 (en) Topical composition
GB0911428D0 (en) Composition
ZA201204017B (en) Topical foam composition
GB0909362D0 (en) Composition
GB201020601D0 (en) Topical formulation
GB0908642D0 (en) Composition
GB0901966D0 (en) Composition
EP2394634A4 (en) Hesperidin-containing composition
GB0906779D0 (en) Composition
GB0922389D0 (en) composition
GB0911294D0 (en) Composition
GB0904941D0 (en) Composition
EP2444061A4 (en) Apigenin-containing composition
GB201006350D0 (en) Composition
GB0904942D0 (en) Composition
GB0918590D0 (en) Composition
GB0903688D0 (en) Composition
IL197464A0 (en) Foamable topical composition
GB0922133D0 (en) Composition
GB0902959D0 (en) Composition